Related Experiment Video
Updated: Jun 27, 2026
10:40
Adipose-Derived Mesenchymal Stromal Cells Co-Cultured with Primary Mixed Glia to Reduce Prion-Induced Inflammation
Published on: August 11, 2023
Mesenchymal stem cells and neurodegenerative disease
1Burden Neurological Institute, University of Bristol Institute of Clinical Neurosciences, Frenchay Hospital, Bristol, UK.
Clinical Pharmacology and Therapeutics
|December 19, 2008
Summary
Cell therapy shows promise for neurodegenerative diseases. Cautious pilot studies using autologous mesenchymal stem cells (MSCs) are suggested due to their probable safety and current biological understanding.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Stem Cell Biology
Background:
- Neurodegenerative diseases represent a significant unmet medical need.
- Cell therapy offers a potential therapeutic avenue for these conditions.
- Patient and scientific enthusiasm for cell therapy is high.
Purpose of the Study:
- To evaluate the potential of autologous mesenchymal stem cells (MSCs) for treating neurodegenerative diseases.
- To balance therapeutic promise with rigorous scientific methodology and patient safety.
- To determine if cautious pilot clinical studies are warranted.
Main Methods:
- Review of current understanding of mesenchymal stem cell (MSC) biology.
- Assessment of the probable safety profile of autologous MSCs.
- Consideration of methodological rigor in clinical trial design.
Main Results:
- Mesenchymal stem cells (MSCs) possess biological characteristics relevant to neurodegenerative disease.
- Autologous MSCs appear to have a favorable safety profile for preliminary investigation.
- A balance between scientific understanding and safety supports cautious clinical exploration.
Conclusions:
- Cautious pilot clinical studies using autologous mesenchymal stem cells (MSCs) are tentatively proposed.
- Methodological rigor and patient safety are paramount in advancing cell therapy for neurodegenerative conditions.
- Further research into MSC biology and safety is essential to inform clinical translation.
Related Concept Videos
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:15Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...